Company Number: 13203519

Analysis Date: 2025-07-29 17:16 UTC

Financial Health Assessment Report: ESPANOVUS LTD

---

1. Financial Health Score: D

Explanation:
The company's financial health is concerning, primarily due to negative net asset values and net current liabilities. While the business is operational and filing accounts on time, the financials reveal symptoms of distress that need urgent attention to avoid deterioration.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Fixed Assets	307	Very low tangible asset base, typical for a micro-entity service business; limited capital investment.
Current Liabilities	9,556	Liabilities due within one year, significantly higher than assets, indicating short-term obligations.
Net Current Assets (Working Capital)	-9,556	Negative working capital—business owes more short-term than it owns, a key symptom of liquidity risk.
Total Assets Less Current Liabilities (Net Assets)	-9,249	Negative equity position, indicating liabilities exceed assets, a major red flag for solvency.
Shareholders Funds	-9,249	Reflects accumulated losses, indicating the business is technically insolvent on balance sheet terms.
Employees	1	Micro-sized company with a very small workforce, consistent with micro-entity status.
Share Capital	1	Minimal share capital, common for micro private companies.
Filing Status	Up to date	No overdue filings; compliance with legal obligations is good.

---

3. Diagnosis: What the Financial Data Reveals

ESPANOVUS LTD is operating as a micro-entity with minimal fixed assets and a very small team. However, the company shows clear symptoms of financial distress:

• Negative Net Assets (-£9,249): This is akin to a patient whose vital organ is failing. The business has more debts than assets, indicating potential insolvency. This situation could undermine stakeholder confidence, including suppliers, customers, and lenders.

• Negative Working Capital (-£9,556): The company’s short-term liabilities exceed its current assets, signaling liquidity problems. This is like having a healthy blood pressure but poor circulation—the company might struggle to meet immediate obligations.

• Growth in Liabilities: Current liabilities have risen sharply from £2,758 in 2023 to £9,556 in 2024, a worrying trend that indicates increasing financial pressure.

• Stable but Minimal Operations: The company employs only one person and has not significantly grown its asset base, indicating a very lean operation but also limited capacity to generate strong cash flows.

• No Shareholders’ Equity Cushion: With only £1 in share capital and accumulated losses, the business lacks a financial buffer to absorb shocks.

Despite these issues, the company remains active, compliant, and under the control of a sole director with full ownership, which may help streamline decision-making.

---

4. Recommendations: Steps to Improve Financial Wellness

1. Improve Liquidity Management:

   • Prioritize reducing current liabilities, possibly through negotiating extended payment terms with creditors or restructuring debts.
   • Boost cash reserves by accelerating receivables or reducing discretionary spending.

2. Seek Additional Capital Injection:

   • The company should consider infusing new equity capital or securing a loan to strengthen the balance sheet and provide a cushion against ongoing losses.

3. Enhance Revenue Generation:

   • Increase marketing or diversify services to improve sales. Given the company operates in healthcare recruitment and consultancy, leveraging digital channels and partnerships could help.

4. Cost Control and Efficiency:

   • Review operational expenses critically to ensure the business is not overextended. Streamline processes and seek cost-effective solutions.

5. Regular Financial Monitoring:

   • Establish monthly cash flow forecasts and budget controls to detect and respond to symptoms of financial stress early.

6. Professional Advice:

   • Engage with a financial advisor or business turnaround specialist to develop a structured recovery plan.

---

Medical Analogy Summary

ESPANOVUS LTD currently exhibits symptoms akin to a patient with low blood pressure and weak circulation—its liquidity and solvency (vital signs) are compromised. Without intervention, the financial condition could deteriorate further, risking "organ failure" (insolvency). However, with prompt treatment—capital infusion, cost management, and revenue improvement—the prognosis can improve.

---